These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22027798)

  • 1. Endophthalmitis after injections of anti-vascular endothelial growth factor drugs.
    Stewart MW
    Retina; 2011 Nov; 31(10):1981-2. PubMed ID: 22027798
    [No Abstract]   [Full Text] [Related]  

  • 2. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Moshfeghi AA
    Semin Ophthalmol; 2011 May; 26(3):139-48. PubMed ID: 21609227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endophthalmitis is not a "never event".
    Schachat AP; Rosenfeld PJ; Liesegang TJ; Stewart MW
    Ophthalmology; 2012 Aug; 119(8):1507-8. PubMed ID: 22858024
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
    McCannel CA
    Retina; 2011 Apr; 31(4):654-61. PubMed ID: 21330939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Patel SN; Hsu J; Sivalingam MD; Chiang A; Kaiser RS; Mehta S; Park CH; Regillo CD; Sivalingam A; Vander JF; Ho AC; Garg SJ;
    Am J Ophthalmol; 2021 Feb; 222():194-201. PubMed ID: 32888902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. We congratulate the authors for publishing their data on bilateral consecutive intravitreal injections administered in their office.
    Shah GY; Ambatipudi S; Fernandes M; Lakshmipathy M; Varma PV; Sachdeva V; Pathengay A
    Retina; 2010 Sep; 30(8):1325-6; author reply 1326-7. PubMed ID: 20827150
    [No Abstract]   [Full Text] [Related]  

  • 7. LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.
    Freiberg FJ; Brynskov T; Munk MR; Sørensen TL; Wolf S; Wirth MA; Becker M; Michels S
    Retina; 2017 Dec; 37(12):2341-2346. PubMed ID: 28099318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ
    Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections.
    Ristau T; Kirchhof B; Fauser S
    Acta Ophthalmol; 2014 Sep; 92(6):e494-6. PubMed ID: 24460667
    [No Abstract]   [Full Text] [Related]  

  • 10. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting.
    Brynskov T; Kemp H; Sørensen TL
    Retina; 2014 May; 34(5):951-7. PubMed ID: 24317292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral endophthalmitis following bilateral same-day anti-VEGF injections.
    Sepetis AE; Clarke B; Gupta B
    Acta Ophthalmol; 2021 Feb; 99(1):e131-e133. PubMed ID: 32533656
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical antibiotics to reduce the risk of endophthalmitis after intravitreal injection?
    Ziemssen F; Bartz-Schmidt KU
    Arch Ophthalmol; 2010 Sep; 128(9):1222-3; author reply 1223-4. PubMed ID: 20837814
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of endophthalmitis after intravitreal injections at a tertiary care hospital.
    Zafar S; Hamid A; Bin Mahmood SU; Burq MA; Maqsood N
    Can J Ophthalmol; 2018 Apr; 53(2):94-97. PubMed ID: 29631833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS.
    Reibaldi M; Pulvirenti A; Avitabile T; Bonfiglio V; Russo A; Mariotti C; Bucolo C; Mastropasqua R; Parisi G; Longo A
    Retina; 2018 Jan; 38(1):1-11. PubMed ID: 28267115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Fileta JB; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):143-9. PubMed ID: 24635156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents.
    Storey PP; Patel D; Garg S
    Can J Ophthalmol; 2020 Aug; 55(4):286-292. PubMed ID: 32204888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Writing committee for the Post-Injection Endophthalmitis Study Group, et al.: The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections (Ophthalmology. 2021;128:1620-1626).
    Blom K; Bragadóttir R; Sivertsen MS; Moe MC; Jørstad ØK
    Ophthalmology; 2022 May; 129(5):e61-e62. PubMed ID: 35232584
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing the risk of endophthalmitis after intravitreous injection.
    Kim SJ; Chomsky AS; Sternberg P
    JAMA Ophthalmol; 2013 May; 131(5):674-5. PubMed ID: 23699844
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.
    Bhavsar AR; Stockdale CR; Ferris FL; Brucker AJ; Bressler NM; Glassman AR;
    Arch Ophthalmol; 2012 Jun; 130(6):809-10. PubMed ID: 22801859
    [No Abstract]   [Full Text] [Related]  

  • 20. NOVEL CASE OF CLOSTRIDIUM PERFRINGENS ENDOPHTHALMITIS AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION.
    Kadaba VR; Menon J
    Retin Cases Brief Rep; 2020; 14(2):181-182. PubMed ID: 29176524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.